Wombat you're right in the sense that peripheral IV isn't under consideration for the AML EMD trial.
But central line would slow down the breast cancer trial so much that's it's better to wait until peripheral IV is available. Which is the point that the original poster had overlooked.
I'm glad you're following the debates and contributing.
General Comments / Chat, page-6436
-
-
- There are more pages in this discussion • 5,045 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
0.050(3.08%) |
Mkt cap ! $285.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.75 | $1.64 | $210.4K | 125.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 1.645 |
1 | 12000 | 1.630 |
2 | 4461 | 1.625 |
1 | 5000 | 1.620 |
2 | 10500 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 595 | 1 |
1.695 | 7597 | 2 |
1.700 | 11000 | 1 |
1.730 | 2399 | 1 |
1.750 | 952 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |